Works by Tawbi, Hussein

Results: 66
    1

    Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.

    Published in:
    2019
    By:
    • Schvartsman, Gustavo;
    • Ma, Junsheng;
    • Bassett, Roland L.;
    • Haydu, Lauren E.;
    • Amaria, Rodabe Navroze;
    • Hwu, Patrick;
    • Wong, Michael K.;
    • Hwu, Wen‐Jen;
    • Diab, Adi;
    • Patel, Sapna Pradyuman;
    • Davies, Michael A.;
    • Hamerschlak, Nelson;
    • Tawbi, Hussein Abdul‐Hassan;
    • Glitza Oliva, Isabella C.;
    • Bassett, Roland L Jr;
    • Hwu, Wen-Jen;
    • Tawbi, Hussein Abdul-Hassan
    Publication type:
    journal article
    2
    3

    Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

    Published in:
    Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 499, doi. 10.1007/s11060-019-03121-2
    By:
    • Ferguson, Sherise D.;
    • Bindal, Shivani;
    • Bassett, Roland L.;
    • Haydu, Lauren E.;
    • McCutcheon, Ian E.;
    • Heimberger, Amy B.;
    • Li, Jing;
    • O'Brien, Barbara J.;
    • Guha-Thakurta, Nandita;
    • Tetzlaff, Michael T.;
    • Tawbi, Hussein;
    • Davies, Michael A.;
    • Glitza, Isabella C.
    Publication type:
    Article
    4
    5
    6
    7

    Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions.

    Published in:
    Pigment Cell & Melanoma Research, 2020, v. 33, n. 4, p. 527, doi. 10.1111/pcmr.12861
    By:
    • Glitza, Isabella C.;
    • Smalley, Keiran S. M.;
    • Brastianos, Priscilla K.;
    • Davies, Michael A.;
    • McCutcheon, Ian;
    • Liu, James K. C.;
    • Ahmed, Kamran A.;
    • Arrington, John A.;
    • Evernden, Brittany R.;
    • Smalley, Inna;
    • Eroglu, Zeynep;
    • Khushalani, Nikhil;
    • Margolin, Kim;
    • Kluger, Harriet;
    • Atkins, Michael B.;
    • Tawbi, Hussein;
    • Boire, Adrienne;
    • Forsyth, Peter
    Publication type:
    Article
    8

    Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.

    Published in:
    Pigment Cell & Melanoma Research, 2019, v. 32, n. 3, p. 458, doi. 10.1111/pcmr.12771
    By:
    • Eroglu, Zeynep;
    • Holmen, Sheri L.;
    • Chen, Qing;
    • Khushalani, Nikhil I.;
    • Amaravadi, Ravi;
    • Thomas, Reena;
    • Ahmed, Kamran A.;
    • Tawbi, Hussein;
    • Chandra, Sunandana;
    • Markowitz, Joseph;
    • Smalley, Inna;
    • Liu, James K. C.;
    • Chen, Yian Ann;
    • Najjar, Yana G.;
    • Karreth, Florian A.;
    • Abate‐Daga, Daniel;
    • Glitza, Isabella C.;
    • Sosman, Jeffrey A.;
    • Sondak, Vernon K.;
    • Bosenberg, Marcus
    Publication type:
    Article
    9
    10

    Immunotherapeutic Approaches to Sarcoma.

    Published in:
    Current Treatment Options in Oncology, 2015, v. 16, n. 6, p. 1, doi. 10.1007/s11864-015-0345-5
    By:
    • Burgess, Melissa;
    • Tawbi, Hussein
    Publication type:
    Article
    11

    A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 5, p. 721, doi. 10.1007/s00280-022-04430-6
    By:
    • Manzo, Julia;
    • Puhalla, Shannon;
    • Pahuja, Shalu;
    • Ding, Fei;
    • Lin, Yan;
    • Appleman, Leonard;
    • Tawbi, Hussein;
    • Stoller, Ronald;
    • Lee, James J.;
    • Diergaarde, Brenda;
    • Kiesel, Brian F.;
    • Yu, Jing;
    • Tan, Antoinette R.;
    • Belani, Chandra P.;
    • Chew, Helen;
    • Garcia, Agustin A.;
    • Morgan, Robert J.;
    • Wahner Hendrickson, Andrea E.;
    • Visscher, Daniel W.;
    • Hurley, Rachel M.
    Publication type:
    Article
    12

    Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 4, p. 643, doi. 10.1007/s00280-021-04317-y
    By:
    • Maguire, William F.;
    • Schmitz, John C.;
    • Scemama, Jonas;
    • Czambel, Ken;
    • Lin, Yan;
    • Green, Anthony G.;
    • Wu, Shaoyu;
    • Lin, Huang;
    • Puhalla, Shannon;
    • Rhee, John;
    • Stoller, Ronald;
    • Tawbi, Hussein;
    • Lee, James J.;
    • Wright, John J.;
    • Beumer, Jan H.;
    • Chu, Edward;
    • Appleman, Leonard J.
    Publication type:
    Article
    13
    14

    Chordoma: The Nonsarcoma Primary Bone Tumor.

    Published in:
    Oncologist, 2007, v. 12, n. 11, p. 1344, doi. 10.1634/theoncologist.12-11-1344
    By:
    • Chugh, Rashmi;
    • Tawbi, Hussein;
    • Lucas, David R.;
    • Biermann, J. Sybil;
    • Schuetze, Scott M.;
    • Baker, Laurence H.
    Publication type:
    Article
    15
    16

    Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 22, p. 8650, doi. 10.1002/cam4.3474
    By:
    • Fischer, Grant M.;
    • Carapeto, Fernando C. L.;
    • Joon, Aron Y.;
    • Haydu, Lauren E.;
    • Chen, Huiqin;
    • Wang, Fuchenchu;
    • Van Arnam, John S.;
    • McQuade, Jennifer L.;
    • Wani, Khalida;
    • Kirkwood, John M.;
    • Thompson, John F.;
    • Tetzlaff, Michael T.;
    • Lazar, Alexander J.;
    • Tawbi, Hussein A.;
    • Gershenwald, Jeffrey E.;
    • Scolyer, Richard A.;
    • Long, Georgina V.;
    • Davies, Michael A.
    Publication type:
    Article
    17
    18
    19
    20

    Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.

    Published in:
    2019
    By:
    • Appleman, Leonard J.;
    • Beumer, Jan H.;
    • Jiang, Yixing;
    • Lin, Yan;
    • Ding, Fei;
    • Puhalla, Shannon;
    • Swartz, Leigh;
    • Owonikoko, Taofeek K.;
    • Donald Harvey, R.;
    • Stoller, Ronald;
    • Petro, Daniel P.;
    • Tawbi, Hussein A.;
    • Argiris, Athanassios;
    • Strychor, Sandra;
    • Pouquet, Marie;
    • Kiesel, Brian;
    • Chen, Alice P.;
    • Gandara, David;
    • Belani, Chandra P.;
    • Chu, Edward
    Publication type:
    journal article
    21

    Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors.

    Published in:
    2016
    By:
    • Sarantopoulos, John;
    • Goel, Sanjay;
    • Chung, Vincent;
    • Munster, Pamela;
    • Pant, Shubham;
    • Patel, Manish;
    • Infante, Jeffrey;
    • Tawbi, Hussein;
    • Becerra, Carlos;
    • Bruce, Justine;
    • Kabbinavar, Fairooz;
    • Lockhart, A.;
    • Tan, Eugene;
    • Yang, Shu;
    • Carlson, Gary;
    • Scott, Jeffrey;
    • Sharma, Sunil;
    • Patel, Manish R;
    • Lockhart, A Craig;
    • Scott, Jeffrey W
    Publication type:
    journal article
    22
    23
    24

    Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 11, p. 1961, doi. 10.1093/neuonc/noab094
    By:
    • Tawbi, Hussein A;
    • Forsyth, Peter A;
    • Hodi, F Stephen;
    • Lao, Christopher D;
    • Moschos, Stergios J;
    • Hamid, Omid;
    • Atkins, Michael B;
    • Lewis, Karl;
    • Thomas, Reena P;
    • Glaspy, John A;
    • Jang, Sekwon;
    • Algazi, Alain P;
    • Khushalani, Nikhil I;
    • Postow, Michael A;
    • Pavlick, Anna C;
    • Ernstoff, Marc S;
    • Reardon, David A;
    • Puzanov, Igor;
    • Kudchadkar, Ragini R;
    • Tarhini, Ahmad A
    Publication type:
    Article
    25

    A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.

    Published in:
    OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.1898105
    By:
    • Slingluff jr, Craig L.;
    • Zarour, Hassane M.;
    • Tawbi, Hussein Abdul-Hassan;
    • Kirkwood, John M.;
    • Postow, Michael A.;
    • Friedlander, Philip;
    • Devoe, Craig E.;
    • Gaughan, Elizabeth M.;
    • Mauldin, Ileana S.;
    • Olson jr, Walter C.;
    • Smith, Kelly T.;
    • Macri, Mary J.;
    • Ricciardi, Toni;
    • Ryan, Aileen;
    • Venhaus, Ralph;
    • Wolchok, Jedd D.
    Publication type:
    Article
    26

    Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.

    Published in:
    OncoImmunology, 2017, v. 6, n. 12, p. N.PAG, doi. 10.1080/2162402X.2017.1361097
    By:
    • Reuben, Alexandre;
    • Petaccia de Macedo, Mariana;
    • McQuade, Jennifer;
    • Joon, Aron;
    • Ren, Zhiyong;
    • Calderone, Tiffany;
    • Conner, Brandy;
    • Wani, Khalida;
    • Cooper, Zachary A.;
    • Tawbi, Hussein;
    • Tetzlaff, Michael T.;
    • Padera, Robert F.;
    • Durand, Jean-Bernard;
    • Lazar, Alexander J.;
    • Wargo, Jennifer A.;
    • Davies, Michael A.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022.

    Published in:
    Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04100-y
    By:
    • Ascierto, Paolo A.;
    • Blank, Christian;
    • Eggermont, Alexander M.;
    • Garbe, Claus;
    • Gershenwald, Jeffrey E.;
    • Hamid, Omid;
    • Hauschild, Axel;
    • Luke, Jason J.;
    • Mehnert, Janice M.;
    • Sosman, Jeffrey A.;
    • Tawbi, Hussein A.;
    • Mandalà, Mario;
    • Testori, Alessandro;
    • Caracò, Corrado;
    • Osman, Iman;
    • Puzanov, Igor
    Publication type:
    Article
    36
    37

    Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1001150
    By:
    • Ho, Joel;
    • Mattei, Jane;
    • Tetzlaff, Michael;
    • Williams, Michelle D.;
    • Davies, Michael A.;
    • Diab, Adi;
    • Oliva, Isabella C. Glitza;
    • McQuade, Jennifer;
    • Patel, Sapna P.;
    • Tawbi, Hussein;
    • Wong, Michael K.;
    • Fisher, Sarah B.;
    • Hanna, Ehab;
    • Keung, Emily Z.;
    • Ross, Merrick;
    • Weiser, Roi;
    • Su, Shirley Y.;
    • Frumovitz, Michael;
    • Meyer, Larissa A.;
    • Jazaeri, Amir
    Publication type:
    Article
    38
    39
    40

    Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 5, p. 975, doi. 10.1002/cncr.34004
    By:
    • Patel, Anisha B.;
    • Farooq, Sahira;
    • Welborn, Macartney;
    • Amaria, Rodabe N.;
    • Chon, Susan Y.;
    • Diab, Adi;
    • Glitza Oliva, Isabella C.;
    • Huen, Auris O.;
    • Li, Shirley Q.;
    • Nelson, Kelly C.;
    • Pacha, Omar;
    • Patel, Sapna P.;
    • Rapini, Ronald P.;
    • Tawbi, Hussein A.;
    • Wong, Michael K.;
    • McQuade, Jennifer;
    • Davies, Michael A.;
    • Haydu, Lauren E.
    Publication type:
    Article
    41
    42
    43

    Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.

    Published in:
    2017
    By:
    • Schuetze, Scott M.;
    • Bolejack, Vanessa;
    • Choy, Edwin;
    • Ganjoo, Kristen N.;
    • Staddon, Arthur P.;
    • Chow, Warren A.;
    • Tawbi, Hussein A.;
    • Samuels, Brian L.;
    • Patel, Shreyaskumar R.;
    • Mehren, Margaret;
    • D'Amato, Gina;
    • Leu, Kirsten M.;
    • Loeb, David M.;
    • Forscher, Charles A.;
    • Milhem, Mohammed M.;
    • Rushing, Daniel A.;
    • Lucas, David R.;
    • Chugh, Rashmi;
    • Reinke, Denise K.;
    • Baker, Laurence H.
    Publication type:
    journal article
    44
    45
    46
    47
    48

    Prevention of Brain Metastases: A New Frontier.

    Published in:
    Cancers, 2024, v. 16, n. 11, p. 2134, doi. 10.3390/cancers16112134
    By:
    • Pellerino, Alessia;
    • Davidson, Tara Marie;
    • Bellur, Shreyas S.;
    • Ahluwalia, Manmeet S.;
    • Tawbi, Hussein;
    • Rudà, Roberta;
    • Soffietti, Riccardo
    Publication type:
    Article
    49
    50

    Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.

    Published in:
    Cancers, 2021, v. 13, n. 21, p. 5301, doi. 10.3390/cancers13215301
    By:
    • Sloane, Robert A. Szczepaniak;
    • White, Michael G.;
    • Witt, Russell G.;
    • Banerjee, Anik;
    • Davies, Michael A.;
    • Han, Guangchun;
    • Burton, Elizabeth;
    • Ajami, Nadim;
    • Simon, Julie M.;
    • Bernatchez, Chantale;
    • Haydu, Lauren E.;
    • Tawbi, Hussein A.;
    • Gershenwald, Jeffrey E.;
    • Keung, Emily;
    • Ross, Merrick;
    • McQuade, Jennifer;
    • Amaria, Rodabe N.;
    • Wani, Khalida;
    • Lazar, Alexander J.;
    • Woodman, Scott E.
    Publication type:
    Article